Biyani Biosolutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-07-2024
- Paid Up Capital ₹ 0.10 M
as on 12-07-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 M
as on 12-07-2024
- Revenue -7.12%
(FY 2020)
- Profit -58.07%
(FY 2020)
- Ebitda -84.78%
(FY 2020)
- Net Worth 20.54%
(FY 2020)
- Total Assets -24.21%
(FY 2020)
About Biyani Biosolutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.00 M.
Sujata Biyani, Priyanka Biyani, Madhu Biyani, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900RJ2014PTC044773
- Company No.
044773
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Biyani Biosolutions?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sujata Biyani  | Director | 17-May-2017 | Current |
| Priyanka Biyani | Director | 17-May-2017 | Current |
| Madhu Biyani | Director | 04-Jan-2014 | Current |
| Manish Biyani | Director | 04-Jan-2014 | Current |
Financial Performance of Biyani Biosolutions.
Biyani Biosolutions Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 7.12% decrease. The company also saw a substantial fall in profitability, with a 58.07% decrease in profit. The company's net worth Soared by an impressive increase of 20.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biyani Biosolutions?
In 2019, Biyani Biosolutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biyani Institute Of Commerce And Managem Ent LlpActive 3 years 2 monthsSujata Biyani and Priyanka Biyani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 23 Nov 2022 | ₹3.00 M | Open |
Canara Bank Creation Date: 23 Nov 2022 | ₹5.00 M | Open |
How Many Employees Work at Biyani Biosolutions?
Unlock and access historical data on people associated with Biyani Biosolutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biyani Biosolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biyani Biosolutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
